Author Correction: Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need

Affiliations

¹ Wellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
² Wellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK. i.h.gilbert@dundee.ac.uk.

Published Erratum

Mark C Field et al. Nat Rev Microbiol. 2018 Nov.

. 2018 Nov;16(11):714.

doi: 10.1038/s41579-018-0085-1.

¹ Wellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
² Wellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK. i.h.gilbert@dundee.ac.uk.

Abstract

The structures of nifurtimox in Table 1 were incorrect and have been updated in the pdf and online. The authors apologize for any confusion caused.

Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.
Field MC, Horn D, Fairlamb AH, Ferguson MA, Gray DW, Read KD, De Rycker M, Torrie LS, Wyatt PG, Wyllie S, Gilbert IH. Field MC, et al. Nat Rev Microbiol. 2017 Feb 27;15(4):217-231. doi: 10.1038/nrmicro.2016.193. Online ahead of print. Nat Rev Microbiol. 2017. PMID: 28239154 Free PMC article. Review.